or on the link below. It is well known that quality sleep is crucial to many areas of health. Obstructive sleep apnea (OSA) is one of the most common sleep disorders, affecting approximately 39 ...

As obesity medicine continues to evolve, integrating sleep health into obesity treatment plans is essential.Poor sleep ...

The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity -- the first medication approved for ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

The Food and Drug Administration (FDA) has approved Zepbound ® (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound is a dual ...

Cost matters, and there is room for guardrails. But cutting coverage altogether or creating barriers that disrupt care risks ...

Insulin resistance, obesity, age, and hormones may increase your risk of developing co-occurring PCOS and sleep apnea. But researchers still aren’t sure of the exact cause. These conditions co-occur ...

If you've been diagnosed with sleep apnea, you likely already know that a continuous positive airway pressure (CPAP) device ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Sleep apnea can result in daytime fatigue and irritability. Obstructive Sleep Apnea, defined ...

The FDA has expanded the approval of Eli Lillys obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity -- the first medication approved for ...